Sherwin-Williams (SHW) PT Lowered to $425.00 at Barclays

Sherwin-Williams (NYSE:SHW) had its price target reduced by stock analysts at Barclays from $450.00 to $425.00 in a report issued on Friday, Marketbeat.com reports. The brokerage currently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays’ price objective indicates a potential upside of 14.73% from the stock’s current price.

SHW has been the subject of several other reports. Citigroup cut Sherwin-Williams from a “buy” rating to a “neutral” rating and reduced their price target for the company from $492.00 to $435.00 in a report on Wednesday, October 10th. Jefferies Financial Group reissued a “hold” rating and issued a $465.00 price target on shares of Sherwin-Williams in a report on Wednesday, July 25th. Northcoast Research reissued a “buy” rating and issued a $465.00 price target on shares of Sherwin-Williams in a report on Friday, July 27th. Morgan Stanley raised their price target on Sherwin-Williams from $425.00 to $455.00 and gave the company an “overweight” rating in a report on Tuesday, July 17th. Finally, Zacks Investment Research cut Sherwin-Williams from a “buy” rating to a “hold” rating in a report on Thursday, October 18th. Ten equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Sherwin-Williams currently has a consensus rating of “Buy” and a consensus target price of $466.74.

SHW opened at $370.44 on Friday. The company has a quick ratio of 0.75, a current ratio of 1.04 and a debt-to-equity ratio of 2.19. The company has a market capitalization of $34.59 billion, a PE ratio of 20.66, a price-to-earnings-growth ratio of 1.50 and a beta of 1.24. Sherwin-Williams has a 12 month low of $355.28 and a 12 month high of $479.64.



Sherwin-Williams (NYSE:SHW) last posted its quarterly earnings results on Thursday, October 25th. The specialty chemicals company reported $5.68 EPS for the quarter, missing the consensus estimate of $5.71 by ($0.03). The business had revenue of $4.73 billion during the quarter, compared to analyst estimates of $4.78 billion. Sherwin-Williams had a net margin of 10.92% and a return on equity of 45.22%. As a group, research analysts forecast that Sherwin-Williams will post 19.14 EPS for the current fiscal year.

In related news, Director David F. Hodnik sold 524 shares of the firm’s stock in a transaction that occurred on Wednesday, August 8th. The stock was sold at an average price of $447.19, for a total value of $234,327.56. Following the completion of the transaction, the director now directly owns 10,105 shares of the company’s stock, valued at approximately $4,518,854.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jane M. Cronin sold 858 shares of the firm’s stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $443.16, for a total value of $380,231.28. Following the completion of the transaction, the senior vice president now directly owns 3,257 shares of the company’s stock, valued at $1,443,372.12. The disclosure for this sale can be found here. Insiders sold a total of 10,301 shares of company stock valued at $4,634,056 over the last ninety days. 0.78% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. LFA Lugano Financial Advisors SA purchased a new position in Sherwin-Williams during the third quarter worth $112,000. Summit Trail Advisors LLC increased its position in Sherwin-Williams by 37,388.4% during the first quarter. Summit Trail Advisors LLC now owns 113,215 shares of the specialty chemicals company’s stock worth $113,000 after buying an additional 112,913 shares in the last quarter. Fort L.P. purchased a new position in Sherwin-Williams during the second quarter worth $124,000. Valeo Financial Advisors LLC increased its position in Sherwin-Williams by 168.6% during the second quarter. Valeo Financial Advisors LLC now owns 325 shares of the specialty chemicals company’s stock worth $142,000 after buying an additional 204 shares in the last quarter. Finally, Moneta Group Investment Advisors LLC increased its position in Sherwin-Williams by 10,109.0% during the second quarter. Moneta Group Investment Advisors LLC now owns 28,279 shares of the specialty chemicals company’s stock worth $161,000 after buying an additional 28,002 shares in the last quarter. 77.60% of the stock is owned by hedge funds and other institutional investors.

About Sherwin-Williams

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America, the Caribbean, Europe, Asia, and Australia. The company operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group.

Recommended Story: Buyback For Investors Defined

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply